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Abstract 
The entry of animal viruses into cells is mediated by conformational changes in certain virion-particle components. These changes are triggered 
by the binding of virions to receptors and are influenced by low pH during receptor-mediated ndocytosis. These conformational alterations promote 
the interaction of some viral proteins with cellular membranes thereby leading to transient pore formation and the disruption of ionic and pH 
gradients. The entry of toxins that do not possess receptors on the cell surface is promoted during the translocation of the virus genome or the 
nucleocapsid to the cytoplasm. A model is now presented which indicates that efficient virus translocation through cellular membranes requires energy, 
that may be generated by a protonmotive force. The entry of some animal viruses, as promoted bylow pH, should thus only take place when a pH 
gradient and/or a membrane potential exist, but will not take place if these are dissipated, even if virion particles are present in an acidic enviroment. 
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1. Introduction 
For animal viruses to infect cells, translocation of the 
genome to the cell interior is required. Current models 
describing virus entry are based on mechanical interac- 
tions of virion proteins with membranes and no energy 
requirements are envisaged. For viruses such as polio- 
virus or adenovirus, that are devoid of a lipid envelope, 
suggested mechanisms for genome entry involve pore 
formation in membranes, through which the genome 
passess [I]. A further possibility is that the endosomal 
membrane is disrupted [l-3], with the consequent pour- 
ing of the endosomal contents to the cytoplasm. Viruses 
possessing a lipid membrane that surrounds the nucleo- 
capsid contain glycoproteins involved in receptor recog- 
nition and virus entry into cells [4,5]. These viral 
glycoproteins change their conformation, as mediated by 
receptor binding or acidic pH, thereby triggering fusion 
between the virion and cellular membranes [4,5]. Viruses, 
such as Sendai virus, are able to fuse their lipid envelope 
directly with the plasma membrane in a pH-independent 
manner, whereas other viruses, such as Semliki Forest 
virus, fuse their envelope with the endosomal membrane 
upon acidification [6]. Under all circumstances, however, 
fusion is promoted by specialized viral glycoproteins 
whose activity is triggered by conformational changes 
within the glycoprotein [7]. Two major factors can con- 
tribute to these changes: (i) binding of the virus particle 
to the receptor, and/or (ii) low pH [6,8]. The exact contri- 
bution that each of these factors has in the induction of 
conformational changes in virion components during 
virus entry remains to be determined [9,10]. 
*Corresponding author. Fax: (43) (1) 397 4799. 
The fact that a low-pH step is required for the entry 
of some viruses into cells has been taken as evidence that 
an acidic pH is neccessary for the induction of conforma- 
tional changes in the viral fusion glycoprotein [7] and no 
energy requirement has been implicated, provided that 
fusion takes place [5]. Nevertheless, this simple model 
does not explain several experimental findings including, 
for example, the efficient translocation of other macro- 
molecules into cells by virus particles [1 1,121. 
2. Virus particles promote the entry of other 
macromolecules into cells 
Viral particles efficiently permeabilize cells to protein 
toxins that, because of the absence of suitable receptors, 
are otherwise unable to cross the membrane [l 1] (see 
Fig. 1). The toxins are efficiently delivered to the cyto- 
plasm shortly after addition of virus to the medium, and 
almost 100% of the cells become permeabilized within a 
few minutes [ 11,13,14]. All animal viruses tested, includ- 
ing Semliki Forest virus, vesicular stomatitis virus, vac- 
cinia virus, adenovirus and poliovirus, induced this phe- 
nomenon [2,11,13-l 51. These findings suggest that the 
viral particle contains a component that not only pro- 
motes the entry of the viral nucleocapsid into the cell, but 
also translocates other macromolecules, that are not 
physically bound to the particles, across the cellular 
membrane to the cytoplasm. Permeabilization of human 
cells by poliovirus to protein toxins during virus entry 
requires the uncoating of virus particles [16] and the 
functioning of the vacuolar proton-ATPase [17-191 (see 
Fig. 1). The use of macrolide antibiotics, such as bafilo- 
mycin Al and concanamycin A, that are selective and 
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Fig. 1. Mechanism of virus entry through receptor-mediated endocytosis. The co-entry of other macromolecules, such as alpha-sarcin, is also shown. 
The blockade of the vacuolar proton-ATPase by bafilomycin A, or the dissipation of the proton gradient by monensin, inhibits the entry of Semliki 
Forest virus (upper panel), but not poliovirus (lower panel). In both cases the co-entry of alpha-sarcin requires an active vacuolar proton-ATPase. 
powerful inhibitors of the vacuolar proton-ATPase is 
crucial to elucidate the molecular mechanisms of virus 
entry and the early membrane permeabilization. Fig. 2 
summarizes the results obtained on the inhibition of 
virus entry and alpha-sarcin co-entry by bafilomycin Al. 
The use of this simple test gives clues about the route 
followed by a given animal virus to infect cells. 
Permeabilization by adenovirus particles has also been 
used to introduce DNA into cells, by employing a recep- 
tor-mediated gene delivery system. Plasmids can bind to 
cells when they are complexed with transferrin-polyly- 
sine molecules [20,21]. The entry of these complexes is 
enhanced when adenovirus particles are present in the 
culture medium. Even the conjugation of influenza 
fusogenic peptides (as derived from the hemagglutinin 
molecule) with the DNA-complexes, enhances gene de- 
livery [22]. Such a synthetic system is similar to a virus 
particle in that nucleic acids are coated with proteins that 
interact with them; these proteins contain a moiety that 
binds the complex to receptors. Nevertheless, although 
this complex is able to bind to the cell suface, it still lacks 
the permeabilizing capacity of virus particles. This prop- 
erty can be provided by the addition of virion particles 
to the system. 
3. Virus entry opens transient pores in the membrane 
Virions modify their conformation upon receptor 
binding thereby allowing the insertion of virion compo- 
nents into the cellular membrane [23,24]. An acidic pH 
might also influence these conformational changes [5], 
although such additional alterations may not be strictly 
required for fusion, since enveloped animal viruses can 
fuse at neutral pH [25] and infect cells that are deficient 
in endosome acidification [9]. It was observed initially by 
Klemperer [26] that absorption of viruses to cells induces 
changes in membrane permeability [12,271. Such changes 
cause the diffusion of cations and protons thereby result- 
ing in a drop in membrane potential [12,27,28]. Indeed, 
once viral proteins are inserted into the membrane they 
are able to open pores, through which protons and other 
ions can pass if the gradient is favorable. Virus particles 
appear to contain structures identical to ion channels 
[29]. Upon insertion in cellular membranes, these struc- 
tures can open pores [30-321. Infectious reovirus subvi- 
ral-particles, induce the formation of multisized channels 
that are permeable to anions [32]. In fibroblasts that 
express the fusogenic hemagglutinin molecule from influ- 
enza virus, l-2 nm wide pores are formed [30]. 
4. Translocation of proteins through membranes requires 
energy 
The insertion of diphteria toxin into a membrane is 
not, by itself, sufficient for the translocation of the 
toxin’s fragment A to the cytoplasm since energy is re- 
quired to push this protein moiety through the mem- 
brane. This energy is provided by a protonmotive force 
L. CarrascolFEBS Letters 350 (1994) 151-154 153 
[33], a mechanism used also for translocation of other 
proteins across membranes [3436]. Still, other toxins, as 
the ricin A chain, are translocated by a pH-independent 
mechanism [37]. Energy in the form of ATP may be, 
instead, required to translocate the ricin A chain [37]. 
In addition to the above energy requirements, protein 
translocation is associated with conformational changes 
in the protein, which allow its interaction with the mem- 
brane and its subsequent translocation to the cytosol. It 
seems possible that virus entry may be mechanistically 
similar and may be dependent on the existence of a pH 
gradient, membrane potential, or ATP to translocate the 
genome (or the nucleocapsid) to the cytoplasm. 
5. A protonmotive force model for animal virus entry 
A protonmotive force model (the chemiosmotic hy- 
pothesis) was presented a number of years ago by Mitch- 
ell [38,39] and states that special transducing enzymes 
can use a proton electrochemical gradient to synthesize 
ATP in cells. The translocation of protons through bio- 
logical membranes to generate such a gradient, requires 
energy, but the dissipation of this gradient produces en- 
ergy that can be coupled to non-favorable thermody- 
namic processes. 
A pH gradient is generated in endosomes by the activ- 





Fig. 2. The use of bafilomycin Al to test virus entry and the co-entry 
of the toxin alpha-sarcin indicates the route of entry of a particular 
animal virus. The figure summarizes the results already known [17-191. 
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Fig. 3. Schematic representation of the protonmotive model for animal 
virus entry into cells. The release of the virus nucleocapsid to the 
cytoplasm by enveloped animal viruses that enter through endosomes, 
requires the dissipation of the proton gradient. Accordingly, entry 
would be blocked, not only by increasing the pH in endosomes by 
inhibitors of endosome function, but also by decreasing the pH in the 
cytoplasm. 
ity of the vacuolar proton-ATPase pump. Recently, we 
found that this activity is required both to promote virus 
entry and to drive other macromolecules through the 
lipid barrier of the membrane [17,18]. Thus, I propose a 
new model for animal virus entry that takes into account 
the experimental evidence now available. The model im- 
plies that the viral proteins inserted in the membrane 
may couple the energy liberated by the movement of 
protons (or ions) to the cytoplasm, in favor of its gradi- 
ent, to the translocation of the viral genome (or protein 
toxins) in the same direction. Therefore, the energy accu- 
mulated in endosomes in the form of a pH gradient 
and/or membrane potential is required for the viral nu- 
cleocapsid to enter cells. In addition to virus entry, the 
early permeabilization phenomenon observed with virus 
particles can also be easily rationalized by this proton- 
motive force model. Thus, viral proteins involved in the 
translocation of the viral particle across the membrane 
would also translocate other macromolecules, using an 
existing pH gradient or membrane potential. Therefore, 
the toxin moieties involved in the translocation of toxins 
through membranes behave like virus particles. 
This model implies that certain viral proteins open 
pores in membranes and harness energy for the translo- 
cation of substrates in a non-favorable thermodynamic 
direction. Whereas uncoupling agents dissipate the en- 
ergy stored in ionic gradients, the ‘virus transducing 
complex’ either couples this energy to genome transloca- 
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tion or uses it to promote the passage of proteins or 
protein-nucleic acid complexes to the cytoplasm. 
Additional support for this model is provided by the 
fact that virions modify membrane potential during 
entry (see reviews [12,27], probably as a consequence of 
the capacity of virion proteins to form ion-channels [30- 
32]. The entry of SFV does not occur when the mem- 
brane potential is abolished by modifying the concentra- 
tion of monovalent cations, even under acidic conditions 
[40]. Even though viruses can attach to dead cells (and 
even to isolated membranes, or truncated receptors) 
[8,41], they only effectively fuse with and enter into cells 
that possess an energized membrane [27]. 
This model would particularly apply to those animal 
viruses that require a low-pH step to infect cells. In this 
instance the virus needs the pH gradient o enter. Viruses 
that enter cells by a pH-independent mechanism could 
rely on the existence of a membrane potential, or be able 
to directly use ATP as the energy source to translocate 
their genome into the cytoplasm. Therefore, it is possible 
that different viruses use different mechanisms for 
genome translocation, the point is to determine if all of 
them require energy during this step of virus infection. 
The mechanical and the protonmotive force models 
can be differentiated experimentally. The low-pH model, 
that explains the entry of enveloped viruses into cells, 
indicates that a low pH is sufficient o allow virus fusion 
and entry in a mechanistic way. Thus, low pH changes 
the conformation of a protein that is inserted into the 
cellular membrane and fusion ensues. The protonmotive 
force model indicates that low pH is not, by itself, suffi- 
cient for virus entry. Thus, under low pH conditions 
virus infection will be blocked if the pH gradient is de- 
stroyed (see Fig. 3). Alterations in the cytoplasmic pH 
or ion concentration also interphere with the endocytotic 
process [4,5,42]. Therefore, destruction of the pH gradi- 
ent may be required for virus genome translocation and 
for an intact endocytic pathway. Future studies on this 
exciting field of virus entry, which will be directed to- 
wards elucidating the exact molecular basis underlying 
both virus genome delivery into cells and the early mem- 
brane permeabilization that is induced by virion particles 
should indicate which of these models is the closest to 
reality. 
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